Zhenxing Biopharmaceutical & Chemical Co. Ltd. | Ownership
Companies that own Zhenxing Biopharmaceutical & Chemical Co. Ltd.
China Asset Management Co., Ltd.
3,570,113
1.35%
-7,224,685
0.07%
03/31/2018
Penghua Fund Management Co., Ltd.
1,099,173
0.41%
-3,401,967
0.05%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
855,381
0.32%
-2,207,041
0.05%
12/31/2017
AEGON-INDUSTRIAL Fund Management Co., Ltd.
742,944
0.28%
-11,168,948
0.05%
12/31/2017
Harvest Fund Management Co., Ltd.
390,500
0.15%
-414,000
0.01%
12/31/2017
New China Fund Management Co., Ltd.
146,665
0.06%
-813,409
0.04%
12/31/2017
HuaAn Fund Management Co., Ltd.
16,000
0.01%
-11,800
0%
12/31/2017
China Universal Asset Management Co., Ltd.
0
0%
-693,578
0%
12/31/2017
E Fund Management Co., Ltd.
0
0%
-626,634
0%
12/31/2017
Bosera Asset Management Co., Ltd.
0
0%
-577,643
0%
12/31/2017
About Zhenxing Biopharmaceutical & Chemical Co.
View Profile
| Address |
16/F, Gaoxin International Building
Taiyuan Shanxi 030006
China
|
|
Employees
|
- |
| Website |
- |
| Updated |
07/08/2019 |
| Zhenxing Biopharmaceutical & Chemical Co., Ltd. engages in the production and marketing of pharmaceutical products. It specializes in human serum albumin, intravenous human immunoglobulin, human immunoglobulin, human hepatitis B immunoglobulin, tetanus human immunoglobulin, and rabies immunoglobulin. The company was founded on May 22, 1995 and is headquartered in Taiyuan, China. |
